• Diet and Targeted Therapy With Drs. Dellon and Hirano
    May 19 2023

    In this podcast, expert clinicians will discuss diet considerations and targeted therapy for treatment of EoE.

    Show more Show less
    30 mins
  • Steroids and PPIs in the Treatment of EoE With Drs. Dellon and Beveridge
    May 19 2023

    In this podcast, expert clinicians will discuss the role of steroids and PPIs for treatment of EoE.

    Show more Show less
    23 mins
  • Differential Diagnosis of EoE With Drs. Dellon and Chehade
    May 19 2023

    In this podcast, expert clinicians will discuss best practices for the differential diagnosis of EoE.

    Show more Show less
    26 mins
  • Pearls From the Pros on IBD Management: Anti-Integrin and S1P Receptor Modulation in IBD Practice With Drs. David Rubin and Maria Abreu
    Jan 6 2022

    In this podcast, expert clinicians discuss the latest updates on anti-integrin therapy and S1P receptor modulators in IBD management.

    Show more Show less
    25 mins
  • Pearls From the Pros on IBD Management: JAK Inhibition in IBD Practice With Drs. David Rubin and Millie Long
    Jan 6 2022

    In this podcast, expert clinicians discuss the latest updates on JAK inhibition in IBD management.

    Show more Show less
    21 mins
  • Pearls From the Pros on IBD Management: Anti-IL-12/23 in IBD Practice With Drs. David Rubin and Bruce Sands
    Jan 6 2022

    In this podcast, expert clinicians discuss the latest updates on anti-IL-12/23 therapy in IBD management.

    Show more Show less
    17 mins
  • Pearls From the Pros on IBD Management: Anti-TNF Therapy in IBD Practice With Drs. David Rubin and Stephen Hanauer
    Jan 6 2022

    In this podcast, expert clinicians discuss the latest updates on anti-TNF therapy in IBD management.

    Show more Show less
    22 mins
  • Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky
    Aug 18 2021

    In this podcast, expert clinicians compare the immunogenicity of available biologic therapies and explore options for managing patients who develop anti-drug antibodies. 

    Show more Show less
    13 mins